Related Experiment Video
Updated: Aug 2, 2026
07:33
Intralymphatic Immunotherapy and Vaccination in Mice
Published on: February 2, 2014
Vaccines and vaccinations. The strategic issues
1Department of Clinical Sciences, College of Veterinary Medicine, North Carolina State University, Raleigh, North Carolina, USA. richard_ford@ncsu.edu
Summary
Companion animal vaccine technology is rapidly advancing, presenting challenges for veterinarians. Future reviews of current vaccines and protocols will require careful consideration of safety and efficacy.
Area of Science:
- Veterinary Medicine
- Immunology
Background:
- Companion animal vaccine technology is rapidly advancing.
- Diagnostic and vaccine technologies are improving.
- Concerns regarding vaccine safety are prevalent.
Purpose of the Study:
- To address the challenges faced by veterinarians regarding companion animal vaccines.
- To discuss the implications of new vaccine technologies and safety concerns.
Main Methods:
- Literature review of current trends in veterinary vaccinology.
- Analysis of diagnostic and vaccine technology advancements.
- Examination of vaccine safety concerns in companion animals.
Main Results:
- Veterinarians face significant challenges due to the rapid proliferation of companion animal vaccines.
- Advances in technology necessitate a review of existing vaccine protocols.
- Ongoing scrutiny of vaccine safety is a critical issue.
Conclusions:
- The veterinary field must adapt to evolving vaccine technologies and safety considerations.
- Future veterinary practice will involve navigating complex decisions regarding companion animal vaccination.
- A proactive approach to vaccine review and protocol development is essential.
Related Concept Videos
01:51Vaccinations
Overview
01:30Cancer Vaccines
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
01:29Microorganisms in Medicine and Therapeutics
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
01:23Vaccine Production
Vaccine production involves a sequence of upstream and downstream processes to generate a safe and effective immunological product. It begins with cultivating microorganisms, such as viruses or bacteria, to obtain antigenic material. For viral vaccines, mammalian host cells are grown in bioreactors and subsequently infected with the target virus. The virus replicates within the host cells, which are lysed to release viral particles. This lysate is then clarified through filtration or...
01:21Vaccines
Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the type of...
01:24Smallpox
Smallpox is a severe contagious disease caused by the Variola major virus, a double-stranded DNA member of the Poxviridae family.Variola major transmission occurs primarily via inhalation of virus-laden droplets or direct contact with infectious scabs. The incubation period averages approximately seven days, although it may range from 7 to 17 days depending on the inoculum and host factors.Clinically, the prodromal phase is marked by an abrupt onset of high fever, malaise, headache, and myalgia.